Literature DB >> 21298661

Metabolomic profiling of human plasma in pancreatic cancer using pressurized capillary electrochromatography.

Huiping Zhang1, Yan Wang, Xue Gu, Junyi Zhou, Chao Yan.   

Abstract

The application of pressurized capillary electrochromatography (pCEC) coupled with ultra violet (UV) detection has been investigated for the production of global metabolite profiles from human plasma, and its capabilities of classifying pancreatic cancer patients. The pCEC separation of plasma samples was performed on a RP column with gradient elution. The applied voltage, detection wavelength and type of acid modifiers on separation of plasma samples were optimized with pooled quality control (QC) sample. The stability and the repeatability of the methodology were also determined by the repeat analysis of QC sample. The effects of different scaling methods on the results of orthogonal partial least-squares discrimination analysis (OPLS-DA) based on pCEC-UV data set were also investigated. The results of the current study clearly showed the different phenotypes of metabolites of pancreatic cancer patients and healthy controls based on pCEC-UV plasma profiles. OPLS-DA data are shown to provide a valuable means of convenient classification. This work indicated that pCEC-UV method can be used as a cost-effective and information-rich, while relatively simple and inexpensive approach for plasma profiling on disease metabolomics studies.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Year:  2011        PMID: 21298661     DOI: 10.1002/elps.201000431

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  10 in total

1.  A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.

Authors:  Nguyen Phuoc Long; Sang Jun Yoon; Nguyen Hoang Anh; Tran Diem Nghi; Dong Kyu Lim; Yu Jin Hong; Soon-Sun Hong; Sung Won Kwon
Journal:  Metabolomics       Date:  2018-08-10       Impact factor: 4.290

2.  Identification of ENTPD8 and cytidine in pancreatic cancer by metabolomic and transcriptomic conjoint analysis.

Authors:  Yong An; Huihua Cai; Yong Yang; Yue Zhang; Shengyong Liu; Xinquan Wu; Yunfei Duan; Donglin Sun; Xuemin Chen
Journal:  Cancer Sci       Date:  2018-09-03       Impact factor: 6.716

3.  Pancreatic carcinoma, pancreatitis, and healthy controls: metabolite models in a three-class diagnostic dilemma.

Authors:  Alexander Benedikt Leichtle; Uta Ceglarek; Peter Weinert; Christos T Nakas; Jean-Marc Nuoffer; Julia Kase; Tim Conrad; Helmut Witzigmann; Joachim Thiery; Georg Martin Fiedler
Journal:  Metabolomics       Date:  2012-11-06       Impact factor: 4.290

4.  Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.

Authors:  Takao Itoi; Masahiro Sugimoto; Junko Umeda; Atsushi Sofuni; Takayoshi Tsuchiya; Shujiro Tsuji; Reina Tanaka; Ryosuke Tonozuka; Mitsuyoshi Honjo; Fuminori Moriyasu; Kazuhiko Kasuya; Yuichi Nagakawa; Yuta Abe; Kimihiro Takano; Shigeyuki Kawachi; Motohide Shimazu; Tomoyoshi Soga; Masaru Tomita; Makoto Sunamura
Journal:  Int J Mol Sci       Date:  2017-04-04       Impact factor: 5.923

5.  Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of ¹H-NMR Spectroscopy and Gas Chromatography-Mass Spectrometry.

Authors:  Yarrow J McConnell; Farshad Farshidfar; Aalim M Weljie; Karen A Kopciuk; Elijah Dixon; Chad G Ball; Francis R Sutherland; Hans J Vogel; Oliver F Bathe
Journal:  Metabolites       Date:  2017-01-13

Review 6.  Review and Comparison of Cancer Biomarker Trends in Urine as a Basis for New Diagnostic Pathways.

Authors:  Carmen Bax; Beatrice Julia Lotesoriere; Selena Sironi; Laura Capelli
Journal:  Cancers (Basel)       Date:  2019-08-25       Impact factor: 6.639

7.  xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data.

Authors:  Karan Uppal; Quinlyn A Soltow; Frederick H Strobel; W Stephen Pittard; Kim M Gernert; Tianwei Yu; Dean P Jones
Journal:  BMC Bioinformatics       Date:  2013-01-16       Impact factor: 3.169

8.  Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting.

Authors:  J Xiong; J Bian; L Wang; J-Y Zhou; Y Wang; Y Zhao; L-L Wu; J-J Hu; B Li; S-J Chen; C Yan; W-L Zhao
Journal:  Blood Cancer J       Date:  2015-03-13       Impact factor: 11.037

9.  Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics.

Authors:  Miki Watanabe; Sulaiman Sheriff; Kenneth B Lewis; Junho Cho; Stuart L Tinch; Ambikaipakan Balasubramaniam; Michael A Kennedy
Journal:  J Mol Biomark Diagn       Date:  2012-03-12

10.  Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.

Authors:  Khyati Y Mehta; Hung-Jen Wu; Smrithi S Menon; Yassi Fallah; Xiaogang Zhong; Nasser Rizk; Keith Unger; Mark Mapstone; Massimo S Fiandaca; Howard J Federoff; Amrita K Cheema
Journal:  Oncotarget       Date:  2017-08-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.